Scribe Therapeutics Expands Collaboration With Biogen to Second Target
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St futures fall as yields and oil rebound; Fed minutes in focus
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Musk rules out TSMC role in Terafab operations; Intel gains
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 222.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $222.89 | 52 Week High | $333.65 | |||
| Open | $222.89 | 52 Week Low | $223.02 | |||
| Day High | $222.89 | P/E | 28.54 | |||
| Day Low | $222.89 | EPS | $7.81 | |||
| Volume | 141 | |||||
